160 related articles for article (PubMed ID: 12946101)
1. A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury.
Ezquerro IJ; Lasarte JJ; Dotor J; Castilla-Cortázar I; Bustos M; Peñuelas I; Blanco G; Rodríguez C; Lechuga Mdel C; Greenwel P; Rojkind M; Prieto J; Borrás-Cuesta F
Cytokine; 2003 Apr; 22(1-2):12-20. PubMed ID: 12946101
[TBL] [Abstract][Full Text] [Related]
2. Thymosin β4 suppresses CCl
Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
[TBL] [Abstract][Full Text] [Related]
4. A synthetic peptide from transforming growth factor-β₁ type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats.
Baltanás A; Miguel-Carrasco JL; San José G; Cebrián C; Moreno MU; Dotor J; Borrás-Cuesta F; López B; González A; Díez J; Fortuño A; Zalba G
Antioxid Redox Signal; 2013 Nov; 19(14):1607-18. PubMed ID: 23350688
[TBL] [Abstract][Full Text] [Related]
5. Ginkgo biloba extract alleviates liver fibrosis induced by CCl in rats.
Ding J; Yu J; Wang C; Hu W; Li D; Luo Y; Luo H; Yu H
Liver Int; 2005 Dec; 25(6):1224-32. PubMed ID: 16343076
[TBL] [Abstract][Full Text] [Related]
6. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis.
George J; Roulot D; Koteliansky VE; Bissell DM
Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12719-24. PubMed ID: 10535989
[TBL] [Abstract][Full Text] [Related]
7. Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats.
Roulot D; Sevcsik AM; Coste T; Strosberg AD; Marullo S
Hepatology; 1999 Jun; 29(6):1730-8. PubMed ID: 10347115
[TBL] [Abstract][Full Text] [Related]
8. Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3.
Shaaban AA; Shaker ME; Zalata KR; El-kashef HA; Ibrahim TM
Chem Biol Interact; 2014 Jan; 207():81-91. PubMed ID: 24144775
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta gene expression in normal and fibrotic rat liver.
De Bleser PJ; Niki T; Rogiers V; Geerts A
J Hepatol; 1997 Apr; 26(4):886-93. PubMed ID: 9126804
[TBL] [Abstract][Full Text] [Related]
10. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
Chen A
Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
[TBL] [Abstract][Full Text] [Related]
11. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
[TBL] [Abstract][Full Text] [Related]
12. Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice.
Niu L; Cui X; Qi Y; Xie D; Wu Q; Chen X; Ge J; Liu Z
PLoS One; 2016; 11(5):e0156090. PubMed ID: 27224286
[TBL] [Abstract][Full Text] [Related]
13. The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats.
Lang Q; Liu Q; Xu N; Qian KL; Qi JH; Sun YC; Xiao L; Shi XF
Biochem Biophys Res Commun; 2011 Jun; 409(3):448-53. PubMed ID: 21600192
[TBL] [Abstract][Full Text] [Related]
14. The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis.
Kim KH; Kim HC; Hwang MY; Oh HK; Lee TS; Chang YC; Song HJ; Won NH; Park KK
Biochem Biophys Res Commun; 2006 May; 343(4):1072-8. PubMed ID: 16579972
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis.
Kanzler S; Lohse AW; Keil A; Henninger J; Dienes HP; Schirmacher P; Rose-John S; zum Büschenfelde KH; Blessing M
Am J Physiol; 1999 Apr; 276(4):G1059-68. PubMed ID: 10198351
[TBL] [Abstract][Full Text] [Related]
16. Ameliorative effect of Ganoderma lucidum on carbon tetrachloride-induced liver fibrosis in rats.
Lin WC; Lin WL
World J Gastroenterol; 2006 Jan; 12(2):265-70. PubMed ID: 16482628
[TBL] [Abstract][Full Text] [Related]
17. [Effects of perindopril and valsartan on the expression of TGF beta 1 and TGF beta receptor II mRNA, Smad3 and Smad7 in experimental hepatic fibrotic rats].
Gong ZJ; Song SL; Huang YQ; Ruan P
Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):737-40. PubMed ID: 15619341
[TBL] [Abstract][Full Text] [Related]
18. Rhein inhibits liver fibrosis induced by carbon tetrachloride in rats.
Guo MZ; Li XS; Xu HR; Mei ZC; Shen W; Ye XF
Acta Pharmacol Sin; 2002 Aug; 23(8):739-44. PubMed ID: 12147197
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 Scaffolding Domain Peptides Alleviate Liver Fibrosis by Inhibiting TGF-β1/Smad Signaling in Mice.
Lu J; Zhang J; Wang Y; Sun Q
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891777
[TBL] [Abstract][Full Text] [Related]
20. [Effects of Anluohuaxianwan on transforming growth factor-β1 and related signaling pathways in rats with carbon tetrachloride-induced liver fibrosis].
Lu W; Gao YH; Wang ZZ; Cai YS; Yang YQ; Miao YQ; Pei F; Liu XE; Zhuang H
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):257-262. PubMed ID: 28494543
[No Abstract] [Full Text] [Related]
[Next] [New Search]
